Immune hematology : diagnosis and management of autoimmune cytopenias / Jenny M. Despotovic, editor.
Despotovic, Jenny M.
2018
RC600
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
Immune hematology : diagnosis and management of autoimmune cytopenias / Jenny M. Despotovic, editor.
ISBN
9783319732695 (electronic book)
3319732692 (electronic book)
3319732684
9783319732688
DOI
https://doi.org/10.1007/978-3-319-73269-5
Publication Details
Cham, Switzerland : Springer, c2018.
Language
English
Description
1 online resource : ill.
Item Number
10.1007/978-3-319-73269-5 doi
Call Number
RC600
Dewey Decimal Classification
616.978
Summary
This text provides a concise yet comprehensive overview of the most common autoimmune cytopenias affecting adults and children. The book is divided into four sections, each of which focuses on a major autoimmune cytopenia. The first section features background, pathophysiology, presentation, evaluation, and treatment strategies for immune thrombocytopenia (ITP), the most common cause of antibody-mediated platelet destruction. The second section reviews common forms and treatment strategies for autoimmune hemolytic anemia (AIHA), including a chapter dedicated specifically to Evans Syndrome. The third section comprehensively reviews the pathophysiology, diagnosis and current management approaches to thrombotic thrombocytopenic purpura (TTP), a potentially life-threatening autoimmune syndrome. The book concludes with a final section on autoimmune neutropenia. Each section includes a review of common underlying systemic autoimmune conditions and immune deficiency syndromes that can accompany or cause autoimmune cytopenias. Written by experts in each content area, Immune Hematology: Diagnosis and Management of Autoimmune Cytopenias is a valuable resource for clinicians and professionals who treat patients afflicted with autoimmune cytopenias, including primary care providers, hematologist/oncologists, immunologists, among others.
Bibliography, etc. Note
Includes bibliographical references and index.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file PDF
Source of Description
Description based on print version record.
Added Author
Despotovic, Jenny M.
Available in Other Form
Print version: 9783319732688
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Intro; Preface; Contents; Contributors; Part I: Immune Thrombocytopenia (ITP); Chapter 1: Background of Immune Thrombocytopenia; Introduction; Historical Perspective; Terminology; Presentation; Primary ITP and Secondary ITP; Differential Diagnosis; Conclusion; References; Chapter 2: Pathophysiology of Immune Thrombocytopenia; Platelet Autoantibodies; Balance of Platelet Destruction and Production; Abnormal Megakaryocyte Morphology; Antibody Destruction of Megakaryocytes; Inadequate Thrombopoietin Levels; T Cell-Mediated ITP; T Cell-Propagated Autoantibody Production; Helper T Cell Responses

Role of Th17 CellsRegulatory T cells; B Cell-Mediated ITP; B-Regulatory Cells; Myeloid-Derived Suppressor Cells; Genetic Studies; Secondary ITP; Helicobacter pylori-Related ITP; CMV-Related ITP; Varicella Zoster-Related ITP; Hepatitis C-Related ITP; HIV-Related ITP; Malignancy-Related ITP; Other Autoimmune Disorders; Evans Syndrome; Autoimmune Lymphoproliferative Syndrome (ALPS); References; Chapter 3: Presentation and Evaluation of Immune Thrombocytopenia; Introduction; Clinical Presentation; History; Physical Examination; Bleeding Assessment; Initial Diagnostic Investigations

Diagnostic ApproachAdditional Testing for Suspected ITP; The Role of Bone Marrow Testing; Platelet Antibody Testing; Screening Tests for Associated Conditions; Infectious Triggers for ITP: Hepatitis C, HIV, and H. pylori; Autoimmune Conditions; Immunodeficiencies; Summary; References; Chapter 4: The Treatment of Immune Thrombocytopenia; Introduction; General Treatment Considerations; Who Should Be Treated?; First-Line Management; Corticosteroids; Mechanism of Action; Steroid Treatment Recommendations; Intravenous Immunoglobulin; Mechanism of Action; IVIG Treatment Recommendations

Anti-D ImmunoglobulinMechanism of Action; Anti-D Treatment Recommendations; Second-Line Therapy; Splenectomy; Mechanism of Action; Splenectomy Treatment Recommendations; Rituximab; Mechanism of Action; Rituximab Treatment Recommendations; Thrombopoietin Receptor Agonists (TPO-RAs); Mechanism of Action; TPO-RA Adverse Effects; Treatment Recommendations; Use of TPO-RAs in Pediatric ITP; Use of TPO-RAs in Newly Diagnosed ITP; Management of Life-Threatening Bleeding; Other Agents; Antimetabolites; Novel Therapies; References; Part II: Autoimmune Hemolytic Anemia (AIHA)

Chapter 5: Background, Presentation and Pathophysiology of Autoimmune Hemolytic AnemiaHistory of Immune Hemolysis; Definitions and Classification; Warm AIHA; Pathophysiology; Clinical Features; Cold AIHA (Cold Agglutinin Disease); Pathophysiology; Clinical Features; Paroxysmal Cold Hemoglobinuria; Pathophysiology; Clinical Features; Mixed AIHA; References; Chapter 6: Treatment of Autoimmune Hemolytic Anemia; Introduction; Diagnosis and Classification; Etiology; Frontline Treatment; Blood Transfusions; Corticosteroids; Second-Line Treatments; Rituximab; Splenectomy; Immunosuppressive Therapies

Browse Subjects

Show more subjects...

Statistics

from
to
Export